T1D RESEARCH BREAKTHROUGHS

THE TOP RESEARCH PROGRESS IN 2018 ~ SUPPORTED BY JDRF  

CGMs IMPROVE HEALTH IN PREGNANCY

An international trial CONCEPTT found that pregnant women living with T1D who used a CGM during their pregnancy had better blood glucose control and healthier babies compared to women who did not use a CGM.

INSULIN PUMP SYSTEM REDUCES HYPOS

In an Australian trial, researchers found a pump that suspends insulin delivery when blood glucose levels fall can halve the amount of time spent in hypoglycaemia in young people with T1D.

BETA CELLS STABILISE AFTER 7YRS

Contrary to older beliefs, new research has found insulin production rapidly declines after diagnosis then stabilises after seven years. This opens new doors to develop methods to preserve and regenerate beta cells in the pancreas years after diagnosis

DRUGS REDUCE EARLY SIGNS OF KIDNEY DISEASE IN YOUNG ADULTS WITH T1D

A global adolescentT1D study has found drugs used to treat blood pressure and cholesterol in adults can reduce the risk of kidney disease in young people with T1D.

TARGETING MICROORGANISMS IN THE GUT COULD PREVENT T1D

Australian researchers discovered that genetics contribute to shaping the gut environment and the changes happen before T1D is diagnosed.

IMMUNOTHERAPY HAS THE POTENTIAL TO DELAY THE PROGRESS OF T1D

UK researchers tested a new immune therapy in humans for the first time and found that it was safe and has the potential to delay progression of T1D.

BLOOD PRESSURE DRUG BOOSTS INSULIN PRODUCTION

UK researchers found a common blood pressure drug called verapamil protected working beta cells and boosted insulin production in adults with recently diagnosed T1D.

COMBINATION IMMUNOTHERAPY PRESERVES BETA CELL FUNCTION

Global prevention group TrialNet found low dose immune therapy preserves beta cell function, improves insulin production and reduces HbA1c in recently diagnosed individuals with T1D.

AUSTRALIAN RESEARCHERS IDENTIFY WHICH BABIES COULD DEVELOP T1D

Researchers identified a seven-gene ‘signature’ in babies under 12 months old, which when combined with a genetic risk score, identified those with a high-risk of developing T1D.

NEW WAYS TO TREAT EYE DAMAGE CAUSED BY T1D

Australian research in mice discovered the surprising presence of immune cells within the eye, which when boosted, were able to reduce eye damage.

© 2018. Created by JDRF Australia & Nomads

ABN 40 002 286 553

DGR 042 753